Lomustine (INN), abbreviated CCNU is an alkylating nitrosourea compound used
in chemotherapy. It is closely related to semustine and is in the same family as ...
Lomustine (CCNU) is usually taken as a single dose only once every 6 weeks.
Do NOT take a dose of lomustine (CCNU) more than once within a 6-week period
Mar 15, 2016 ... Lomustine can cause a severe decrease in the number of blood cells in your
bone marrow. A decrease in the number of blood cells in your ...
Apr 28, 2015 ... Read about the cancer treatment drug lomustine, otherwise known as CCNU,
including what it is, how it works and possible side effects.
(lomustine). Capsules. WARNINGS. CeeNU (lomustine) should be administered
under the supervision of a qualified physician experienced in the use of cancer ...
Lomustine is a nitrosourea with antineoplastic activity. Lomustine alkylates and
crosslinks DNA, thereby inhibiting DNA and RNA synthesis. This agent also ...
Find patient medical information for lomustine oral on WebMD including its uses,
side effects and safety, interactions, pictures, warnings and user ratings.
Dec 1, 2015 ... Lomustine is used alone or in combination with other medicines to treat brain
tumors, Hodgkin's disease, and other kinds of cancer.
Jan 6, 2016 ... Lomustine is an alkylating agent used in the treatment of brain tumors and
Name, Lomustine. Accession Number, DB01206 (APRD00292). Type, Small
Molecule. Groups, Approved. Description. An alkylating agent of value against